Gastro-oesophageal reflux disease: Medical or surgical treatment? Report of an interactive workshop

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 12, 1997, Pages 785-789

  Schwab, G P ^a,h   Blum, A L ^b   Bodner, E ^a   Dallemagne, B ^c   Glaser, K ^a   Koop, H ^d   Pace, F ^e   Rosch W ^g   Siewert, J R ^f   Wetscher, G ^a  

^a Universitatsklinik fur Chirurgie Innsbruck   (Austria)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c Clinique Saint Joseph   (Belgium)

^d MARTIN LUTHER KRANKENHAUS   (Germany)

^e UNIVERSITY OF MILAN   (Italy)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g KRANKENHAUS NORDWEST   (Germany)

^h UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Barrett's metaplasia; Gastro oesophageal reflux disease; Laparoscopic antireflux surgery; Protein pump inhibitors

Indexed keywords

PROTON PUMP INHIBITOR;

ANTIREFLUX OPERATION; ARTICLE; GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; HUMAN; LAPAROSCOPIC SURGERY; MEDICAL DECISION MAKING; MEDICAL PRACTICE; PRIORITY JOURNAL; RECURRENT DISEASE; SURGEON; TREATMENT PLANNING;

EID: 14444274588     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00372.x     Document Type: Article

References (24)

1. Redmond EJ, Wetscher G. Introduction. In: Hinder RA, ed. Gastroesophageal Reflux disease. Austin: RG Landes Company, 1993.
2. Wetscher GJ, Redmond EJ, Vitito LM. Pathophysiology of gastroesophageal reflux disease. In: Hinder RA, ed. Gastroesophageal Reflux disease. Austin: RG Landes Company, 1993.
3. Dodds WJ, Hogan WJ, Helm JF, Dent J. Pathogenesis of reflux esophagitis. Gastroenterology 1981; 81: 376-94.
4. Stein HJ, Barlow AP, DeMeester TR, Hinder RA. Complications of gastroesophageal reflux disease. Ann. Surg. 1992; 216: 35-43.
5. Hinder RA, Filipi CJ, Wetscher G, Neary P, DeMeester TR, Perdikis G. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann. Surg. 1994; 220: 472-83.
6. Armstrong D, Emde C, Inauen W, Blum AL. Diagnostic assessment of gastroesophageal reflux disease: what is possible versus what is practical? Hepatogastroenterology 1992; 39 (Suppl. 1): 3-13.
7. Coley CM, Barry MJ, Spechler SJ, Williford WO, Mulley AG. Initial medical versus surgical therapy for complicated of chronic gastroesophageal reflux disease (GERD): a cost-effectiveness analysis. Gastroenterology 1993; 104: A5.
8. Heudebert G, Marks R, Wilcox C, Centor R. Cost-effectiveness of omeprazole versus fundoplication in the longterm treatment of reflux esophagitis. Gastroenterology 1996; 110: A19.
9. Büchler, MW, Frei E, Kleiber CH, Krähenbühl L. Gastroesophageal reflux disease (GERD): back to surgery? In: Büchler MW, Frei E, Kleiber CH, Krähenbühl L, eds. Progress in Surgery vol. 23. Basel: Karger, 1997.
10. Lieberman DA. Medical Therapy for chronic reflux esophagitis. Arch. Int. Med. 1987; 147: 1717-20.
11. Wetscher GJ, Glaser K, Gadenstätter M et al. Gastroesophageal reflux disease associated with poor esophageal body motility is effectively treated by laparoscopic Toupet fundoplication. ACA 1996; 1: 49-54.
12. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric function and Barrett's carcinoma. Gastroenterology 1995; 109: 1541-6.
13. Fiorucci S, Santucci L, Chiucchiu S, Morelli A. Gastric acidity and gastroesophageal reflux patterns in patients with esophagitis. Gastroenterology 1992; 103: 855-61.
14. Stein HJ, Feussner H, Kauer W, DeMeester TR, Siewert JR. Alkaline gastroesophageal reflux: assessment by ambulatory esophageal aspiration and pH monitoring. Am. J. Surg. 1994; 167: 163-8.
15. DeMeester TR, Attwood SEA, Smyrk TC, Therkildsen DH, Hinder RA. Surgical therapy of Barrett's esophagus. Ann. Surg. 1990; 212: 528-42.
16. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995; 109: 1541-6.
17. Menke-Pluymers MB, Hop WC, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. Cancer 1993; 72: 1155-8.
18. Streitz JM, Ellis FH, Gibb SP, Balogh K, Watkins E. Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann. Surg. 1991; 213: 122-5.
19. Holscher AH, Bollschweiler E, Bumm R, Bartels H, Hofler H, Siewert JR. Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 1995; 118: 845-55.
20. Champion G, Richter JE, Vaezi MF, Singh S, Alexander R. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 1994; 107: 747-54.
21. Clark GWB, Ireland AP, Peters JH, Chandrasoma P, DeMeester TR, Bremner CG. Short segment Barrett's esophagus: a prevalent complication of gastroesophageal reflux disease with malignant potential. Gastroenterology 1996; 110: A1379.
22. Lin KM, Ueda RK, Hinder RA, Stein HJ, DeMeester TR. Etiology and importance of alkaline esophageal reflux. Am. J. Surg. 1991; 162: 553-7.
23. Klinkenberg Knoll EC, Festen HPM et al. Long term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann. Int. Med. 1994; 121: 161-7.
24. Hallerbäck B, Unge P, Carling L et al. Omeprazole or ranitidine in long term treatment of reflux esophagitis. Gastroenterology 1994; 107: 1305-11.